![Susan Doleman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Doleman is currently the Vice President-Clinical Operations at Cyteir Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Epizyme, Inc., a Scientist at The Children's Hospital Corp., and the Vice President-Clinical Development Operations at Replimune Group, Inc. Ms. Doleman received her undergraduate degree from Smith College.
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| EPIZYME, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
The Children's Hospital Corp.
 The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Technik-/Wissenschafts-/F&E-Leiter | - |
| REPLIMUNE GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 5 |
|---|---|
Smith College
 Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Medical/Nursing ServicesHealth Services Provides pediatric care services | Health Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
